In the present study we illustrated that ERK1/2 and p38 inhibitors significantly attenuated CS-induced urocystic EMT in vitro and in vivo, whereas JNK inhibitor failed to exhibit similar effects. This evidence concerns the gene MAPK3 and Cowden syndrome 1.